Recent Finacing
Recent Raise
NanoString provides the nCounter, an automated amplification‑free digital platform for multiplexed profiling of gene expression, miRNA, and copy number variation, and develops diagnostics including a PAM50 breast assay.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors